2738 studies found for:    hormone therapy AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting 1303GCC: Trastuzmab & Pertuzumab Alone or in Combination With Hormonal Therapy or Chemotherapy With Eribulin in Women Aged 60 and Over With HER2/Neu Overexpressed Locally Advanced or MBC
Condition: Metastatic Breast Cancer
Interventions: Drug: Trastuzumab plus Pertuzumab;   Drug: Hormonal Therapy with Anastrozole and Fulvestrant;   Drug: Chemotherapy with Eribulin
2 Completed Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Conditions: Hypercholesterolemia;   Postmenopause
Interventions: Drug: L-arginine;   Drug: Estrogen
3 Recruiting Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Condition: Early Breast Cancer
Intervention: Other: Endocrine therapy interruption
4 Active, not recruiting Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Tamoxifen;   Drug: Toremifene
5 Completed Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Drug: chemotherapy;   Drug: endocrine therapy;   Genetic: DNA methylation analysis;   Genetic: protein analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
6 Recruiting Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With Poor Prognosis, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving 3 Years of Adjuvant Hormone Therapy
Conditions: Primary Non-metastatic Breast Cancer;   Who Remain Disease-free After Receiving at Least 1 Year of Adjuvant Hormone Therapy
Interventions: Drug: Everolimus;   Drug: Placebo
7 Terminated Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention:
8 Completed The Women's Health Initiative Memory Study (The WHIMS Study)
Condition: Dementia Syndromes
Interventions: Drug: Estrogen horomone therapy;   Drug: Estrogen plus progesterone hormone therapy;   Drug: Placebo
9 Recruiting Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Condition: Invasive Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrazole
10 Active, not recruiting Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
Condition: Female Breast Cancer
Intervention: Behavioral: Enhanced information about endocrine therapy
11 Active, not recruiting Compliance to a Hormone Therapy Regimen in Breast Cancer
Condition: Breast Cancer
Interventions: Behavioral: compliance monitoring;   Other: medical chart review;   Other: questionnaire administration
12 Completed Growth Hormone Treatment of Women With Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Growth Hormone;   Drug: Placebo;   Other: Healthy controls
13 Completed Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women
Condition: Postmenopause
Interventions: Drug: Estradiol and Progesterone;   Drug: Estradiol and Drospirenone
14 Completed Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention: Drug: letrozole
15 Completed Study of Paxil Use in Menopausal Women
Condition: Menopause
Interventions: Drug: Paroxetine;   Drug: placebo
16 Active, not recruiting Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Estrogen Receptor Positive;   Progesterone Receptor Positive;   Recurrent Breast Carcinoma;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Questionnaire Administration;   Drug: Tamoxifen Citrate
17 Active, not recruiting Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Conditions: Breast Cancer;   Cancer of the Breast;   Neoplasms, Breast
Intervention: Drug: Estrace followed by anastrazole
18 Active, not recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Letrozole;   Other: Placebo
19 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate
20 Terminated High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Condition: Breast Cancer
Intervention: Biological: esterified estrogens

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years